机构银行市场 - 2025-2030 年预测

机构银行市场预计将从 2025 年的 21.28 亿美元成长到 2030 年的 32.86 亿美元，复合年增长率为 9.07%。

由于医疗和研究领域对新鲜样本和组织的需求不断增长，全球组织库市场正在经历显着增长。组织库收集并储存生物样本以备将来使用，对医疗保健和研究领域的进步至关重要，尤其是在慢性病治疗和组织再生领域。本摘要基于2024年后的市场发展，为产业专家提供了关键的成长动力和地理趋势。

市场成长动力

慢性病治疗中组织需求的增加

在治疗癌症等慢性疾病时对组织的需求不断增长，这是全球组织库市场的主要驱动力。组织库提供再生疗法的重要检体，可应对日益增长的慢性疾病盛行率。在美国，组织库网路非常健全，根据美国组织库协会 (AATB) 报告，美国约有 58 个经过认证的组织库。这些组织库均经过美国食品药物管理局(FDA) 认证，确保符合严格的监管标准。血液组织和细胞占据市场主导地位，反映了它们在再生疗法中的重要角色。政府（尤其是美国）支持在医疗保健中使用组织库，这进一步推动了市场的扩张。

研发进度

专注于组织再生和慢性病治疗的研发活动激增，推动组织库市场的发展。诸如应用干细胞开发各种组织等创新标誌着医学健康研究领域的重大突破。包括艾尔建和汉密尔顿在内的行业巨头正在大力投资组织工程，以加强基于组织的治疗方法的开发和应用。这些研发工作使组织库能够扩大其覆盖范围，并满足对先进治疗解决方案日益增长的需求，从而推动市场成长。

地理视角

北美市场占有率压倒性份额

北美占据全球组织库市场最大份额，这得益于其完善的组织库网路和活跃的组织工程研发。由于主要市场参与者的存在以及慢性病的高发病率，该地区对组织疗法的需求日益增长。尤其是美国，凭藉其先进的医疗基础设施、经FDA认证的组织库以及政府的支持性政策，在组织库市场中处于领先地位。这些因素共同作用，使北美成为技术创新和市场成长的中心。

结论

受慢性病治疗对组织日益增长的需求以及组织工程研究的进步推动，全球组织库市场预计将持续扩张。北美地区凭藉其强大的认证组织库网络以及主要参与者的大量投资，仍然保持市场领先地位。随着医疗和研究领域对组织库的依赖日益加深，预计该市场将保持成长势头，为医疗保健和生物技术行业的相关人员带来重大机会。

本报告的主要优点

• 深刻分析：获得涵盖主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
• 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透。
• 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响市场的未来发展。
• 可行的建议：利用洞察力进行策略决策，在动态环境中开闢新的业务流和收益。
• 适用范围广：对于新兴企业、科学研究机构、顾问公司、中小企业、大型企业都有利且划算。

它有什么用途？

产业和市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

• 2022 年至 2024 年的历史数据和 2025 年至 2030 年的预测数据
• 成长机会、挑战、供应链前景、法律规范与趋势分析
• 竞争定位、策略和市场占有率分析
• 各细分市场和地区（包括国家）的收益成长和预测分析

公司简介

目录

第一章执行摘要

第二章市场概述

• 市场概览
• 市场定义
• 研究范围
• 市场区隔

第三章 商业景气

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策法规
• 策略建议

第四章 技术展望

第五章 机构银行市场（依机构类型）

• 介绍
• 角膜
• 皮肤
• 骨
• 心臟瓣膜
• 其他的

第六章。按储存类型分類的机构银行市场

• 介绍
• 冷冻
• 快速冷冻
• 其他的

第七章 机构银行市场（按应用）

• 介绍
• 治疗
• 研究与开发
• 组织工程
• 其他的

第八章 机构银行市场（依最终用户）

• 介绍
• 医院
• 研究和学术机构
• 其他的

第九章 机构银行市场（按地区）

• 介绍
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 其他的

第十章竞争格局及分析

• 主要企业和策略分析
• 市场占有率分析
• 合併、收购、协议和合作
• 竞争仪錶板

第十一章 公司简介

• Life Link Tissue Bank
• Alamo Biologics
• ViaCord（Revvity Inc.）
• DCI Donor Services Tissue Bank
• Thermo Fisher Scientific Inc.
• Azenta Life Sciences
• Tecan Group Ltd.
• BioLife Solutions, Inc.
• PHC Corporation
• Rokit Healthcare

第十二章 附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要利益
• 调查方法
• 简称

The tissue banking market is expected to grow from USD 2.128 billion in 2025 to USD 3.286 billion in 2030, at a CAGR of 9.07%.

The global tissue banking market is experiencing significant growth, driven by increasing demand for fresh specimens and tissues in medical and research applications. Tissue banks, which collect and store biological specimens for future use, are pivotal in supporting advancements in healthcare and research, particularly in the treatment of chronic diseases and tissue regeneration. This summary highlights key growth drivers and geographical trends based on market developments from 2024 onward, tailored for industry experts.

Market Growth Drivers

Rising Demand for Tissue in Chronic Disease Treatment

The escalating need for tissues to treat chronic conditions, such as cancer, is a primary driver of the global tissue banking market. Tissue banks provide critical specimens used in regenerative therapies, addressing the growing prevalence of chronic disorders. In the United States, the tissue banking network is robust, with approximately 58 accredited tissue banks, as reported by the American Association of Tissue Banks (AATB). These banks are certified by the U.S. Food and Drug Administration (FDA), ensuring compliance with stringent regulatory standards. Blood tissues and cells dominate the market, reflecting their critical role in regenerative treatments. Government support, particularly in the U.S., further accelerates market expansion by promoting tissue bank utilization in healthcare.

Advancements in Research and Development

The surge in research and development (R&D) activities focused on tissue regeneration and chronic disease treatment is propelling the tissue banking market forward. Innovations, such as stem cell applications for developing various tissues, represent significant breakthroughs in the medical and health research sectors. Major industry players, including Allergan and Hamilton Companies, are investing heavily in tissue engineering, enhancing the development and application of tissue-based therapies. These R&D efforts are expanding the scope of tissue banks, enabling them to meet the growing demand for advanced therapeutic solutions and driving market growth.

Geographical Outlook

North America's Dominant Market Share

North America holds the largest share of the global tissue banking market, driven by a well-established network of tissue banks and robust R&D in tissue engineering. The region benefits from the presence of leading market players and a high incidence of chronic diseases, which increase the demand for tissue-based treatments. The U.S., in particular, leads due to its advanced healthcare infrastructure, FDA-accredited tissue banks, and supportive government policies. These factors collectively position North America as the epicenter of tissue banking innovation and market growth.

Conclusion

The global tissue banking market is poised for continued expansion, fueled by the rising need for tissues in chronic disease treatment and advancements in tissue engineering research. North America remains the market leader, supported by a strong network of accredited tissue banks and significant investments from key players. As the medical and research sectors increasingly rely on tissue banks, the market is expected to maintain its growth trajectory, offering substantial opportunities for stakeholders in the healthcare and biotechnology industries.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries

Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Tissue Banking Market Segmentation

By Tissue Type

• Cornea
• Skin
• Bones
• Heart Valves
• Others

By Storage Type

• Cryopreservation
• Deep-Freezing
• Others

By Application

• Therapeutic
• Research & Development
• Tissue Engineering
• Others

By End-User

• Hospitals
• Research & Academic Institutes
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• UK
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Taiwan
• Thailand
• Indonesia
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. TISSUE BANKING MARKET BY TISSUE TYPE

• 5.1. Introduction
• 5.2. Cornea
• 5.3. Skin
• 5.4. Bones
• 5.5. Heart Valves
• 5.6. Others

6. TISSUE BANKING MARKET BY STORAGE TYPE

• 6.1. Introduction
• 6.2. Cryopreservation
• 6.3. Deep-Freezing
• 6.4. Others

7. TISSUE BANKING MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Therapeutic
• 7.3. Research & Development
• 7.4. Tissue Engineering
• 7.5. Others

8. TISSUE BANKING MARKET BY END-USER

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Research & Academic Institutes
• 8.4. Others

9. TISSUE BANKING MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Spain
  • 9.4.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. South Korea
  • 9.6.5. Indonesia
  • 9.6.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Life Link Tissue Bank
• 11.2. Alamo Biologics
• 11.3. ViaCord (Revvity Inc.)
• 11.4. DCI Donor Services Tissue Bank
• 11.5. Thermo Fisher Scientific Inc.
• 11.6. Azenta Life Sciences
• 11.7. Tecan Group Ltd.
• 11.8. BioLife Solutions, Inc.
• 11.9. PHC Corporation
• 11.10. Rokit Healthcare

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key benefits for the stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations